Philadelphia, Pennsylvania--(Newsfile Corp. - December 22, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period").Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to ...

Philadelphia, Pennsylvania--(Newsfile Corp. - December 22, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company") on behalf of investors who purchased or otherwise acquired Skye securities during the period of November 4, 2024 through October 3, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased Skye securities during the Class Period may, no later than ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Laird Superfood, Inc. (NYSE: LSF) and Navitas LLC is fair to Laird shareholders. Halper Sadeh encourages Laird shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Laird and its board violated the federal securities laws and ...

SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and ...

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. and certain senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, with a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [6]. - The company's net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [6]. Stock Price Movement - Following the announcement of disappointing financial results on September 25, 2025, CarMax's stock price dropped by $11.45 per share, or roughly 20%, from $57.05 to $45.60 [7]. - An unexpected departure of CEO Bill Nash on November 6, 2025, along with a weak preliminary Q3 outlook, led to an additional stock price drop of over 24% [7]. Legal Context - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in CarMax securities [3]. - Investors have until January 2, 2026, to request to be appointed to lead the case, which is pending in the U.S. District Court for the District of Maryland [3]. Market Dynamics - CarMax had previously promoted strong demand for its vehicles, which was allegedly inflated by a short-term boost from U.S. tariffs on cars, leading to a "pull forward" in demand [4][6].

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [5][4]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to a range of $1.840 billion to $1.854 billion from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations. The company also projected a poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, over 32%, from $109.11 to $73.89 [6]. Legal Proceedings - Investors have until February 9, 2026, to request to lead the case in the U.S. District Court for the Southern District of New York, under the case caption West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation, et al. [3]. Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs in this case, emphasizing that there are no costs to shareholders for litigation [7][8].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - Synopsys, Inc. provides design automation software products used for designing and testing integrated circuits. Its Design IP segment, which supplies pre-designed silicon components to semiconductor companies, has been the fastest-growing segment, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. Allegations and Financial Performance - The lawsuit claims that Synopsys misled investors by stating that customers relied on its IP to minimize integration risk and that the company was experiencing strength in Europe and South Korea. However, it is alleged that customers required more customization for IP components, negatively impacting the economics of the Design IP business [5]. - In Q3 2025, Synopsys reported a revenue of $425.9 million for its Design IP segment, reflecting a 7.7% year-over-year decline, and a net income of $242.5 million, a 43% year-over-year decline. The company indicated that increased customization demands from customers were affecting its business model [6]. Stock Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys' stock price fell from $604.37 per share to $387.78 per share, a decline of nearly 36%, indicating a significant market reaction to the revealed issues within the company [6].

New York, New York--(Newsfile Corp. - December 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-act ...

Core Viewpoint - The Freeport-McMoRan class action lawsuit alleges violations of the Securities Exchange Act of 1934, focusing on safety issues at the Grasberg mine and the subsequent impact on stock prices due to disclosures of incidents and regulatory risks [1][3][4]. Group 1: Class Action Details - The class action lawsuit is titled Reed v. Freeport-McMoRan Inc., and it allows purchasers of Freeport-McMoRan securities between February 15, 2022, and September 24, 2025, to seek lead plaintiff status by January 12, 2026 [1][7]. - The lawsuit claims that Freeport-McMoRan and its executives made false or misleading statements regarding safety at the Grasberg Block Cave mine, which heightened risks for workers [3][4]. Group 2: Incident and Stock Impact - On September 9, 2025, Freeport-McMoRan reported a significant incident at the Grasberg mine that restricted evacuation routes, leading to a nearly 6% drop in stock price [4]. - Following the tragic fatalities of two team members on September 24, 2025, and the announcement of a potential 35% reduction in production for 2026, the stock price fell nearly 17% [5]. - An article published on September 25, 2025, highlighted the potential strain on Freeport-McMoRan's relationship with the Indonesian government, resulting in an additional stock price drop of over 6% [6]. Group 3: Company Background - Freeport-McMoRan is engaged in mining operations across North America, South America, and Indonesia, with significant operations at the Grasberg Copper and Gold Mine in Papua, Indonesia [2].

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers ...